申请人:Takeda Pharmaceutical Company Limited
公开号:EP2128138A1
公开(公告)日:2009-12-02
The present invention aims to provide an agent for the prophylaxis or treatment of diabetes, which has a superior hypoglycemic action, and is associated with a fewer side effects such as body weight gain and the like.
The present invention relates to an agent for the prophylaxis or treatment of diabetes comprising a compound represented by the formula:
wherein each symbol is as defined in the description, or a salt thereof, or a prodrug thereof.
本发明旨在提供一种用于预防或治疗糖尿病的药物,具有优越的降血糖作用,并且与较少的副作用,如体重增加等相关。本发明涉及一种用于预防或治疗糖尿病的药物,包括由以下式表示的化合物:其中每个符号如描述中所定义,或其盐,或其前药。